Sponsor

Second Affiliated Hospital of Xi'an Jiaotong University

Clinical research sponsor

Published trials17
Recruiting shown2
Roles2
SourceClinicalTrials.gov

Clinical trials

17 shown
A Study on the Efficacy of Immunotherapy, the Occurrence and Severity of Adverse Reactions in Patients with Non-small Cell Lung Cancer in High-altitude AreasNCT06757114 · lead sponsor · 2025-01-01
UNKNOWN
Adibelimab, Famitinib and Chemotherapy for Advanced NSCLC After PD-1 Inhibitor FailureNCT06336954 · lead sponsor · 2024-03-30
NOT_YET_RECRUITING
Characteristics of Intestinal Microbiome in the Progression of Early COPDNCT04876833 · lead sponsor · 2021-05-01
UNKNOWN
Study of Anlotinib Plus Chemoradiotherapy in Patients With Locally Advanced NSCLCNCT04182698 · lead sponsor · 2019-11-22
UNKNOWN
The Effect of Conbercept Injection Through Different Routes for Neovascular GlaucomaNCT03154892 · lead sponsor · 2017-04-01
COMPLETED
Effect of Dexmedetomidine on Levels of Plasma Inflammatory Factor in Asthma Patients Undergoing General AnesthesiaNCT02289391 · lead sponsor · 2014-12-01
UNKNOWN
Laparoscopic Versus Open Devascularization for Portal Hypertension, a Randomized Controlled TrialNCT02178319 · lead sponsor · 2014-06-01
UNKNOWN
Dexmedetomidine Influence on the Level of Perioperative Blood Glucose and Insulin of Elderly Diabetes PatientsNCT02154074 · lead sponsor · 2014-05-01
UNKNOWN
Effect of a Pharmacist-led Multifaceted Intervention on Treatment Outcomes in Hypertensive PatientsNCT06558877 · collaborator · 2025-06-20
RECRUITING
Chronic Airway Disease and Multimorbidity CohortNCT06798077 · collaborator · 2025-02-01
RECRUITING
Non-inferiority Randomized Controlled Trial of Cognitive Targeted Biopsy Versus Software Targeted BiopsyNCT04271527 · collaborator · 2024-02-20
UNKNOWN
ctDNA Analysis to Monitor the Risk of Progression After First-line Immunotherapy in Patients With Advanced NSCLCNCT05198154 · collaborator · 2022-01-24
ACTIVE_NOT_RECRUITING
Efficacy of Pioglitazone Hydrochloride and Metformin Hydrochloride Tablets on the Patients With Newly Diagnosed Type 2 Diabetes Mellitus Combined With Non-alcoholic Fatty Liver DiseaseNCT03796975 · collaborator · 2018-06-28
COMPLETED
NSE/Alb as a Prognostic Biomarker for Lung CancerNCT03724604 · collaborator · 2017-01-01
UNKNOWN
Comparison of Exenatide vs. Biphasic Insulin Aspart 30 on Glucose Variability in Type 2 DiabetesNCT02449603 · collaborator · 2015-11-01
COMPLETED
Efficacy and Safety Study of Sodium Tanshinone IIA Sulfonate on Pulmonary HypertensionNCT01637675 · collaborator · 2013-05-01
UNKNOWN
Study of Qiliqiangxin Capsule to Treat Dilated CardiomyopathyNCT01293903 · collaborator · 2012-01-01
COMPLETED

Sponsor roles

collaborator9
lead sponsor8

How to interpret this record

CureCurrent links normalized diseases, medicines, registry study labels, sponsors and research sites. A link is not the same as a finding of clinical effectiveness. Our research guides explain how to compare studies, decode RxNorm identities, and avoid over-interpreting site and trial counts. See the published database coverage for mapping completeness.

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.